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Purpose: Dose accuracy in the buildup region for radiotherapy treatment planning suffers from
challenges in both measurement and calculation. This study investigates the dosimetry in the
buildup region at normal and oblique incidences for open and IMRT fields and assesses the quality
of the treatment planning calculations.
Methods: This study was divided into three parts. First, percent depth doses and profiles for
55, 1010, 2020, and 3030 cm2 field sizes at 0°, 45°, and 70° incidences were measured
in the buildup region in Solid Water using an Attix parallel plate chamber and Kodak XV film,
respectively. Second, the parameters in the empirical contamination EC term of the convolution/
superposition CVSP calculation algorithm were fitted based on open field measurements. Finally,
seven segmental head-and-neck IMRT fields were measured on a flat phantom geometry and com-
pared to calculations using  and dose-gradient compensation C indices to evaluate the impact of
residual discrepancies and to assess the adequacy of the contamination term for IMRT fields.
Results: Local deviations between measurements and calculations for open fields were within 1%
and 4% in the buildup region for normal and oblique incidences, respectively. The C index with
5%/1 mm criteria for IMRT fields ranged from 89% to 99% and from 96% to 98% at 2 mm and 10
cm depths, respectively. The quality of agreement in the buildup region for open and IMRT fields
is comparable to that in nonbuildup regions.
Conclusions: The added EC term in CVSP was determined to be adequate for both open and IMRT
fields. Due to the dependence of calculation accuracy on 1 EC modeling, 2 internal convolution
and density grid sizes, 3 implementation details in the algorithm, and 4 the accuracy of mea-
surements used for treatment planning system commissioning, the authors recommend an evalua-
tion of the accuracy of near-surface dose calculations as a part of treatment planning
commissioning. © 2010 American Association of Physicists in Medicine.
DOI: 10.1118/1.3377769
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The determination of dose in the buildup region is an impor-
tant issue for radiotherapy of near-surface targets, such as in
the treatment of head-and-neck cancer or breast cancer. Be-
cause target volumes can be close to or extend to the skin,
the skin dose or near-surface tumor dose must be accurately
estimated to avoid unnecessary skin reactions or underdosing
of near-surface target subvolumes. The accuracy of buildup
dose suffers from the challenges in both calculations and
measurements.
Many publications have reported accuracy for various
treatment planning algorithms.1–7 Dose disagreement at near-
surface depths has been found with a range of variation in
these studies. For example, Dogan et al.5 studied the buildup
dose for oblique IMRT beams using a parallel plate chamber
and EDR2 film in a flat phantom. They used the FOCUS
convolution/superposition algorithm to calculate the dose,
and found that the calculated doses at the surface and 1 mm
below the surface were overestimated by 25% and 5%, re-
spectively, for the 0° incident IMRTstrip beam six static
2 416 cm strips. Chung et al. measured the buildup dose
2043 Med. Phys. 37 „5…, May 2010 0094-2405/2010/37„5…/2for IMRT using radiochromic film in a head-and-neck phan-
tom. They found that PINNACLE and CORVUS treatment
planning systems TPSs overestimated the surface dose for
both shallow and deep target cases by 7.4%–18.5% with re-
spect to the prescribed dose. Ramsey et al.3 measured the
buildup dose from helical tomotherapy using TLD and EDR2
film in an anthropomorphic phantom, and found that the cal-
culated surface doses using HI-ART TPS were overestimated
between 3% and 13%.
The sources of the buildup dose are complex and machine
configuration dependent, including the primary photon beam,
backscattered radiation from the patient, and contamination
radiation from accelerator head and air volume. Because of
the complexity of the source of buildup dose, an electron
contamination model is usually added to the photon dose
calculation model for model-based calculation algorithms to
account for the dose contributed by contamination radiation
in the buildup region.8–11 Electron contamination could be
directly measured or indirectly derived by subtracting the
calculated depth dose with photon only from the measured
depth dose.12,13 Magnitude of contamination radiation dose
depends on machine head configuration, energy, depth, field
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the accuracy of the buildup dose calculation strongly de-
pends on the accuracy of the electron contamination model
for various irradiation conditions.
Monte Carlo MC methods have the potential to simulate
physics interactions and provide more accurate dose infor-
mation compared to model-based calculation algorithms. The
MC must accurately model the configuration of the machine
head and fully account for all contamination sources in the
simulation in order to be able to provide accurate buildup
doses. Discrepancies between measurements and MC calcu-
lations have been reported.20,21 However, agreement for 6
MV can be reasonably good. Reported discrepancies at 6
MV are in the range of 3%–4% at 0.5 mm depth20 or 8% at
50 m depth.21 Discrepancies at higher energies can be
much greater.21–23 Contributors to discrepancies could be the
perturbation caused by the presence of the measurement
chamber21 and imprecise description of the treatment head.23
The accuracy of MC calculation in the buildup region re-
mains questionable without better understanding of the
sources of discrepancies.
To validate the accuracy of calculation algorithms in the
buildup region, accurate dose measurement is necessary.
However, it is difficult to measure the dose accurately in a
region without charged particle equilibrium. The detectors
typically used are the extrapolation ion chamber, parallel
plate ion chamber, thermoluminescent dosimeter TLD, di-
ode, MOSFET, and radiochromic film.5,7,15,24–31 In disequi-
librium conditions, the placement of the detector inside the
phantom causes electron fluence perturbations. These pertur-
bations typically cause the detector to over-respond. An ex-
trapolation ion chamber has been proposed as a suitable de-
tector for measurements in the buildup region because the
fluence perturbation can be minimized by the extrapolation
method.32 For evaluation of perturbation factors, the MC
method can be used to investigate the perturbation correction
and improve measurement accuracy.21 Because the use of the
extrapolation chamber is time consuming, a parallel plate ion
chamber is usually used and corrected with empirical over-
response correction factors for buildup dose measurements.
Several studies reported the characteristics of parallel plate
ion chambers, and showed that the chambers over-respond in
the buildup region when compared to extrapolation chamber
measurements. The magnitude of the over-response depends
on energy, field size, chamber design, and incident angle, and
is more pronounced at lower energies.25,33–35
Based on previous reports, the uncertainty of calculated
dose in the buildup region does not solely depend on the
performance of the calculation algorithm, but also depends
on commissioning procedures for buildup region dosimetry,
calculation parameters used for routine calculations, com-
plexity of the treatment plan, etc. Thorough evaluation of the
calculation algorithm would be helpful for proper interpreta-
tion of skin or near-surface tumor doses. To thoroughly
evaluate the performance of a TPS either MC methods or
model-based algorithms, the dose information along central
axis and off-axis must be acquired for simple and complex
irradiation conditions. Therefore, this study was designed to
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IMRT fields for normal and oblique incidences. It is divided
into three parts: 1 Measuring the central axis and off-axis
doses in the buildup region for a range of field sizes and
incident angles; 2 validating the calculation accuracy along
the central axis and off-axis regions in the buildup region and
improving the dose fits in the empirical contamination EC
term of the convolution/superposition CVSP calculation al-
gorithm for open fields; and 3 evaluating the impact of
residual discrepancies and assessing the adequacy of the con-
tamination term for IMRT fields.
II. MATERIALS AND METHODS
II.A. Phantom and measurement setup
An Attix parallel plate chamber RMI Model 449,
Middleton, WI and Kodak X-OMAT V film Eastman
Kodak, Rochester, NY with Solid Water phantom slabs
Gammex RMI Model 457, Middleton, WI were used for
the superficial dose measurements. The lateral dimensions of
the phantom slabs were 3030 or 4040 cm2 with thick-
nesses of 2 mm–5 cm. The slab phantoms were set at 90 cm
source-to-surface distance SSD. A minimum of 10 cm
backscatter was used for all measurements. All measure-
ments were performed with a 6 MV x-ray beam, dose rate of
400 MU/min, jaw only fields MLC parked, and using a
Varian 21EX linear accelerator Varian, Palo Alto, CA
equipped with a Millennium 120 leaf MLC. The accelerator
was calibrated with an output of 0.8 cGy/MU at a depth of
10 cm in water for a 1010 cm2 field size at 90 cm SSD
calibration point.
II.B. Measurements of percent depth dose „PDD… in
the buildup region
The Attix chamber 1 mm electrode gap, 12.7 mm diam-
eter collector, 13.5 mm guard ring width, 4.8 mg /cm2 en-
trance window thickness, fitted in machined Solid Water
slab was used for PDD measurements because it has mini-
mal polarity effect 3.5% at all depths for 1010 cm2
field and minimal over-response 1% for 0° incidence in
the buildup region and can measure the dose near the
surface.34 The doses were measured along the central axis for
field sizes of 55, 1010, 2020, and 3030 cm2, for
incident angles of 0°, 45°, and 70°, and at several depths 0°:
0.2, 0.5, 1.0, 1.5, and 10 cm; 45°: 0.3, 0.6, 0.7, 1.0, 1.4, 5,
and 10 cm slant depth; 70°: 0.6, 0.9, 1.2, 1.5, 5, 9.9, and 10.2
cm slant depth Fig. 1. The number of monitor units MUs
was 100 for all measurements with the Attix chamber. The
accumulated charge was measured with a Therapy Dosimeter
Model 35040 electrometer Chesterland, OH. A total of six
readings for two bias voltages +300 and 300 V were
acquired and averaged. The PDDs were obtained by normal-
izing the dose at measured depths to the dose at 10 cm slant
depth for individual incident angles and field sizes.
To correct the over-response for the Attix chamber in the
buildup region, a modified version of the Rawlinson
35
equations was used. The modified equations incorporate
2045 Hsu et al.: Dose discrepancies in the buildup region 2045the influence of oblique incidences based on the data re-
ported by Gerbi et al.25,33,34 The over-response correction
factors for 6 MV x-rays were determined to be 0.7%, 2.3%,
and 4.2% relative to maximum dose Dmax at the surface for
0°, 45°, and 70° incident angles, respectively. For easier
comparison with calculation, Dmax normalization was con-
verted to D10 dose at 10 cm depth normalization for these
correction factors.
II.C. Measurements of profiles in the buildup region
For measurements using XV film, crossplane profiles
along the direction of leaf motion were measured at several
depths 0°: 0.2, 0.5, 1.5, 5, and 10 cm; 45°: 0.3, 0.6, 1.4, 5,
and 10 cm slant depth; 70°: 0.6, 0.9, 1.5, 5, and 9.9 cm slant
depth for field sizes of 55 and 1010 cm2 and for inci-
dent angles of 0°, 45°, and 70°. The films were placed par-
allel to the phantom surface Fig. 1 and irradiated to
80 cGy to the central axis point on the film. The numbers
of MUs used for exposure were adjusted based on PDDs
from the Attix chamber for different incident angles, field
sizes, and depths. To improve the accuracy of dose determi-
nation, dynamic calibration curves specific for each field
source
source
SSD=90cm
SSD=90cm
FIG. 1. Measurement diagram. The SSD was 90 cm for all incident angles
and the PDDs were measured along the central axis of the beam.
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FIG. 2. An example of EC term for 55 and 1010 cm2 field sizes and
direction perpendicular to the beam axis at 2 mm depth. The EC dose is
−calibration point. EC term parameters are ECMAX=17.6%, EC=0.78 cm , and
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developed using a Kodak X-OMAT 3000RA Processor
Eastman Kodak, Rochester, NY, digitized with a Lumis-
can75 Lumisys, Sunnyvale, CA, and analyzed using in-
house software. The film resolution was 0.150.15 mm2.
To quantify differences between profiles in the buildup re-
gion, the radiological width R50 and the distance between
20% and 80% dose point in the penumbra region were cal-
culated, relative to the dose at central axis for 0° incidence.
For oblique incidences, the slope of the profile was consid-
ered in the determination of R50 and penumbra width.
II.D. CVSP algorithm
The superficial dose calculation was performed using the
University of Michigan treatment planning system UMPlan
and the CVSP algorithm36 with an EC term.37 The EC term
supplements the dose along the central axis using an expo-
nential term with an inplane-crossplane Gaussian blurring
edge function. The exponential term is described by a maxi-
mum ECMAX and linear attenuation factor EC Eq. 1.
The Gaussian blurring edge function is described by standard
deviations EC_inside and EC_outside. Parameters are different
for large 1515 cm2 and small field sizes
1515 cm2.
ECd = ECMAX · FEC_inside,EC_outside · e−EC·d, 1
where d is depth, ECmax is the contamination at surface,
FEC_inside ,EC_outside is a Gaussian edge function of
EC_inside and EC_outside, and EC is an attenuation factor
with depth. In addition, a multiplicative flatness correction
function is used for large fields only. The EC term is depen-
dent on depth, off-axis distance, field size, and energy. IMRT
fields are constrained to use small field parameters.
The field size dependence of the EC term is illustrated in
Fig. 2. The Gaussian blurring edge function not only changes
the magnitude in the off-axis region, but also changes the
magnitude at central axis Eq. 1. If the field size is much
greater than 2 ·EC_inside, then the magnitude at central axis is
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1 EC_inside=EC_outside=3.5 cm.
2046 Hsu et al.: Dose discrepancies in the buildup region 2046not affected by the blurring edge function but the magnitude
decreases when approaching a field edge. If the field size is
comparable to or less than 2 ·EC_inside, the magnitude at cen-
tral axis is decreased due to the blurring edge function and
the magnitude still decreases further when approaching the
field edge. The 1010 cm2 field 2·EC_inside has a small
reduction at central axis, while the 55 cm2 field
2·EC_inside is substantially reduced Fig. 2.
The density, internal convolution, and calculation grid
sizes also affect the accuracy of buildup dose calculation.
The density grid includes all density information acquired
from the anatomical images and its size depends on the scan
acquisition geometry, e.g., the CT image pixelization and the
space between CT slices. For an ideal homogeneous water
phantom, the density grid size has a significant effect near
the surface region only. The internal convolution grid is
placed parallel and perpendicular to the beam axis. The den-
sities for this grid are obtained through interpolation of the
density grid data. The internal convolution grid size depends
on the field size and phantom geometry. The calculated dose
in the internal convolution grid for each beam is transformed
into the dose in the calculation grid so that the dose in all
beams can be accumulated. In this work, all three grid pa-
rameters were set as small as practical typically 1 mm.
The PDDs and profiles were calculated for the smaller
field sizes 55 and 1010 cm2 and all incident angles
0°, 45°, and 70° at 90 cm SSD on a flat phantom with
an internal convolution grid resolution of 111 to
222 mm3, depending on the field size and incident
angle. The calculation and density grid sizes were 1 mm.
The calculations were compared to measurements, and then
the EC term parameters were adjusted, giving preference to
agreement with the normal incidence data using an internal
convolution grid size of 1 mm along the beam axis direction.
The parameters in the EC term were acquired through fitting
the EC exponential equation Eq. 1 to the measured dose
less the calculated dose with photon only along the central
axis in the buildup region for 55 and 1010 cm2 field
sizes at 0° incidence using nonlinear least square method.
Then, the agreement in the off-axis profiles inside the fields
was checked and the EC_outside parameter was manually
tuned to fit off-axis measured profiles outside the fields.
II.E. IMRT fields
Seven segmental IMRT fields were randomly selected
from four head-and-neck patient treatment plans. The con-
straints for leaf sequencing, using step-and-shoot MLC de-
livery based on the method of Bortfeld,38 were number of
segments with maximum of 250 and 1% of calculation
maximum fluence intervals with a 50% fluence offset. Field
size or monitor unit constraints were not used. The total
number of segments of each IMRT field varied from 127 to
285. Three of seven fields were split fields. The dose distri-
butions of seven IMRT fields with beamlet size of
11 cm2 were measured using XV film at 0.2, 0.5, 1.5, and
10 cm depths for 0° incidence and 90 cm SSD. The dose
distributions of oblique incidences 45°: 0.3, 0.6, and 1.4 cm
Medical Physics, Vol. 37, No. 5, May 2010and 70°: 0.6, 0.9, and 1.5 cm were measured for two IMRT
fields out of the seven IMRT fields. Calibration curves for
55 cm2 field size at different depths and angles were used
to convert the film response to dose. All IMRT fields were
recalculated with the new fit parameters under the same mea-
surement condition with an internal convolution grid size
between 111 and 222 mm3.
To quantify the agreement between film measurements
and calculations, dose-gradient compensation C index39,40
was calculated with criteria of 2%/1 mm and 5%/1 mm dose
difference tolerance of maximum dose % and distance pa-
rameter mm for the gradient compensation. For compari-
son, the  index41 was calculated with criteria of 2%/2 mm
and 3%/3 mm dose difference tolerance of maximum dose
% and distance-to-agreement mm. The percentage of
points in agreement C , 1 was calculated for the re-
gion where the dose was higher than 10% of maximum dose
of the measurement i.e., region of interest ROI is the dose
10% of maximum measured dose. The C index with mini-
mal gradient compensation distance parameter of 1 mm
was chosen to focus the analysis on dose level discrepancies.
Using both a tight 2% and a loose 5% dose criteria allows
discrimination of the quality of the data-to-calculation com-
parison of near-surface IMRT dose distributions compared to
IMRT dose distributions at a reference 10 cm depth. Simi-
larly, 2%/2 mm and 3%/3 mm criteria were chosen to repre-
sent the tight and loose criteria for the  index. In addition to
the use of C and  indices to quantify the agreement, the
average deviation for each IMRT field was calculated and
represented the difference relative to the maximum of the
measurement for ROI10% of maximum measured dose.
II.F. Uncertainty analysis
The estimated uncertainty of Attix chamber measurement
in the buildup region is 2% one standard deviation, 1,
including reading variation, error of geometric setup, and
over-response correction. The estimated uncertainty of XV
film measurements for open fields and IMRT fields is 2%,
including geometric setup error and the use of depth-specific
dynamic calibration curves.
III. RESULTS AND DISCUSSION
III.A. Measurement vs calculation for percent depth
doses
Figure 3 shows the PDDs relative to dose at 10 cm depth
for individual field size and incident angle in the buildup
regions for field sizes of 55, 1010, 2020, and
3030 cm2 at 0°, 45°, and 70° incidences. In order to com-
pare with previous reports in the literature, the surface doses
were recalculated relative to Dmax. Results were 9.1%,
15.2%, 27.1%, and 36.9% for 55, 1010, 2020, and
3030 cm2 field sizes at 0° incidence, respectively. Our
results are within 1% for 55 and 1010 cm2, and 3% for
2020 and 3030 cm2 compared to the data reported by
Mellenberg.42 This discrepancy is probably due to varying
contribution from head scatter, where larger differences for
2047 Hsu et al.: Dose discrepancies in the buildup region 2047large fields are expected. Our result is also comparable to the
surface doses summarized by Chiu-Tsao et al.31 which range
from 13% to 20% excluding results from thicker TLDs for
1010 cm2 field size at 6 MV photon beam.
The surface dose increases with increasing incident angle
and field size. There are small increases in surface dose from
0° to 45° incidence, and rapid increases for larger incident
angles. The angular dependence is similar for the four field
sizes studied, largest at the surface and decreasing with in-
creasing depth. The surface dose is approximately linearly
dependent on the length of the side of the square field for the
three incident angles. The surface dose dependence on inci-
dent angle and field size is similar to previous
studies.5,28,29,43,44 Due to the rapid increase in dose with
angle of incidence, careful evaluation for the potential of
skin toxicity should be performed for treatments with large
angles of incidence.
Figure 4 compares PDDs between measurements and cal-
culations to new fit parameters for 55 and 1010 cm2
field sizes at 0°, 45°, and 70° incidences. The dose shown in
the figure is relative to the dose at the calibration point. The
local deviation is percentage of the locally measured dose.
The old EC term parameters were 36.7%, 1.8 cm−1, 1.5 cm,
and 3.5 cm for ECMAX, EC, EC_inside, and EC_outside, re-
0
20
40
60
80
100
120
140
160
180
0 0.3 0.6 0.9 1.2 1.5
Depth (cm)
PD
D
(%
)
5×5
10×10
20×20
30×30
0
20
40
60
80
100
120
140
160
180
0 0.3
S
PD
D
(%
)
(a)
0° 45°
FIG. 3. PDDs for different field sizes at a 0°, b 45°, and c 70° using the
sizes and incident angles. Curves are to guide the eye only.
0
20
40
60
80
100
120
140
160
0 0.3 0.6 0.9 1.2 1.5
Depth (cm)
R
el
at
iv
e
do
se
(%
)
-5
0
5
10
15
Lo
ca
ld
ev
ia
tio
n
(%
)
0
20
40
60
80
100
120
140
160
0 0.3 0.6
Slant
R
el
at
iv
e
do
se
(%
)
(a)
0° 45°
-5
0
5
10
15
20
25
0 0.2D
iff
er
en
ce
(%
)
FIG. 4. Comparison of measured and calculated depth doses for 55 and 1
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dose. Due to the large local deviation at the surface up to 140%, the difference
Medical Physics, Vol. 37, No. 5, May 2010spectively. The new EC term parameters were 17.6%,
0.78 cm−1, 3.5 cm, and 3.5 cm for ECMAX, EC, EC_inside,
and EC_outside, respectively. The local deviation was reduced
from 20% with the old fit parameters to 1% with the new fit
parameters at 2 mm depth at 0° incidence. The local devia-
tion with the new fit parameters is within 1% and 4% at 2
mm–1.5 cm depths for normal and oblique incidences, re-
spectively. The deviation is largest for shallowest depth and
largest incident angle. The average local deviation at depths
from 2 mm to 1.5 cm is 0.5%	1.1%. The calculation accu-
racy for oblique incidences is worse compared to normal
incidence primarily because the parameters in the EC term
were fitted to measured doses at 0° incidence.
The local deviation of surface dose at zero depth was
large, up to 140% at 0° incidence for 55 cm2 field size.
Currently, it is impossible to decrease this discrepancy with-
out deteriorating the agreement at other depths. However, the
difference relative to the dose at the calibration point was
between 12% and 25% for 55 and 1010 cm2 at 0°, 45°,
and 70° incidences see Fig. 4 insets. In addition, the dose at
zero depth is not significant in clinical practice. The depths
from 0.1 epidermal thickness to 2 mm dermal thickness
are of most clinical concern for skin toxicity.29,45 In this
study, the calculation accuracy was estimated through linear
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2048 Hsu et al.: Dose discrepancies in the buildup region 2048interpolation to be within 10% relative to the dose at the
calibration point at 1 mm depth for 0° incidence.
Some factors in the calculation setup were found to affect
the accuracy in the buildup region. The calculated dose var-
ies with internal convolution grid size in the depth direction.
The effect of internal convolution grid size on the calculation
is significant at depths shallower than 5 mm. Figure 5 shows
the influence of internal convolution grid size 1, 1.5, 2, 2.5,
and 3 mm in the depth direction on the dose calculation as a
function of depth shallower than 5 mm for 1010 cm2 field
size at 0° incident angle. The difference is reduced to be
within 2% at depths larger than 5 mm. In this study, the
contamination term was fitted for the calculation with inter-
nal convolution grid size of 1 mm in the depth direction.
Because of the strong dependence of internal convolution
grid size, users must understand the limited accuracy at shal-
lower depths due to grid size effects, possibly increasing the
number of grid points when necessary or fitting the EC term
with the clinically relevant grid size.
Attempts to validate MC calculation and measurement
techniques for surface dose have been mixed, but tend to
agree better at 6 MV compared to higher energies.20–23
Abdel-Rahman et al.21 found the discrepancy for a 6 MV
photon beam was reduced from 26% to 8% in local devia-
tion at 50 m depth after simulating the configuration of
the extrapolation chamber, while the discrepancy for an 18
MV photon beam was only reduced from 37% to 33%. Par-
sai et al.20 reported a discrepancy of up to 3.6% at 0.5 mm
depth for a 6 MV photon beam compared to extrapolation
chamber measurements. Agreement between MC calculation
and measurement in the buildup region depends on the accu-
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FIG. 5. The influence of internal convolution grid size 1 vs 1.5, 2, 2.5, and
3 mm vs depth on the dose calculation for 1010 cm2 field size at 0°
incident angle. The data were acquired through varying internal convolution
grid size in the depth direction with constant size for other grids e.g.,
internal convolution grid size in x and y directions and density grid size.
The local deviation % is the relative difference between doses calculated
with specified grid size and doses calculated with reference 1 mm grid
size. The local deviation is reduced to be within 2% beyond 5 mm depth.
The behavior and magnitude of variation with internal convolution grid size
is similar for 55 cm2 field size.racy of the treatment head simulation and on measurement
Medical Physics, Vol. 37, No. 5, May 2010chamber design and data interpretation.46 Simple agreement
is insufficient. A utility of the MC technique may be to un-
derstand the perturbation of detectors under disequilibrium
conditions and to bolster confidence in surface dose mea-
surement accuracy for a particular machine and detector
setup.
III.B. Measurement vs calculation for profiles
Figure 6 shows the 20%–80% left penumbra widths at
various depths for field sizes of 55 and 1010 cm2, and
incident angles of 0°, 45°, and 70°. Left and right penumbras
represent contralateral and ipsilateral sides relative to the
gantry position for angled beams left side and right side of
Fig. 1, respectively. Generally, the penumbra width in-
creases with increasing depth, field size, and incident angle.
Comparing the measured R50 values and ideal R50 geomet-
ric field at depth for 0° incidence, the differences were
within 1.5 mm. Discrepancies are attributed to measurement
setup error and jaw position error.
Figure 7 shows measured and calculated profiles at shal-
low depths for 55 cm2 at 0°, 45°, and 70° incidences,
relative to the dose at the calibration point. The measured
penumbra is slightly sharper than the calculated penumbra.
The differences between measurements and calculations are
within 1.8 and 1.2 mm for R50 and left and right penumbra
widths, respectively. This difference has no significant de-
pendence on the depth, field size, and incident angle. This
difference was attributed to 1 the volume effect due to de-
tector size when performing algorithm commissioning and
2 the larger internal convolution grid size 11 to 22
mm2 compared to film measurement 0.150.15 mm2.
47,48
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2050 Hsu et al.: Dose discrepancies in the buildup region 2050Another discrepancy in Fig. 7 was the disagreement near
the field periphery at shallow depths, especially for oblique
incidences, where the calculated doses were larger than the
measured doses up to 5% local deviation. The primary
cause is the inappropriate EC modeling in the off-axis region
for oblique incidences when optimal fits were performed.
The off-axis EC is symmetric at normal incidence but not at
oblique incidences. The EC term contribution is also too high
in the off-axis region for oblique incidences. Different mod-
eling of the EC term would be necessary to achieve im-
proved performance at all incident angles.
A main challenge in the profile comparisons was the
ripple in the calculations for oblique incidences. The calcu-
lation ripples shown in Fig. 7c are irregular, appear at shal-
low depths, and disappear at a depth of Dmax and beyond.
The magnitude in the ripple was about 5%. The magnitude
decreases with decreasing internal convolution grid spacing.
The ripple is due to quantization near the phantom-air inter-
face. For purposes of calculation, the phantom is subdivided
into voxels based on the beam axis. The voxels near the
TABLE I. Comparison of film measurements and calculations for seven IMRT
3%/3 mm and C index 2%/1 mm and 5%/1 mm. Shown are percentages of
Split field segment numbers are listed for each subfield. The average doses
ROI10% of the maximum calculated dose and measured dose, respectivel
dose difference calculation minus measurement to the maximum measured
Field No
Depth
cm Segments
Calculation average dose
cGy
Measurement av
cGy
1 0.2 183+101 30 33
1 0.5 183+101 43 46
1 1.5 183+101 50 50
1 10.0 183+101 30 30
2 0.2 237 32 32
2 0.5 237 46 47
2 1.5 237 54 52
2 10.0 237 32 29
3 0.2 127+149 18 19
3 0.5 127+149 26 27
3 1.5 127+149 30 29
3 10.0 127+149 17 17
4 0.2 152+133 21 23
4 0.5 152+133 30 33
4 1.5 152+133 36 35
4 10.0 152+133 22 21
5 0.2 155 30 31
5 0.5 155 42 45
5 1.5 155 49 51
5 10.0 155 30 28
6 0.2 189 28 29
6 0.5 189 40 42
6 1.5 189 47 46
6 10.0 189 28 26
7 0.2 127 19 19
7 0.5 127 27 28
7 1.5 127 31 30
7 10.0 127 19 17surface are assigned densities based on averaging the density
Medical Physics, Vol. 37, No. 5, May 2010inside the voxel, which can include both air and phantom
components. For oblique incidences, voxels are placed ob-
lique to the phantom surface, resulting in nonsmooth densi-
ties and variations in SSD calculation for each surface voxel.
Thus, the ripple phenomenon appears at shallow depths and
increases the difficulty of determination of central axis dose.
In addition to the internal convolution grid size, other factors
which could affect the magnitude of ripple include the reso-
lution of surface description and SSD calculation, calculation
grid size, and density grid size. However, this ripple effect is
less significant in patients’ dosimetry due to nonflat surfaces
and multiple beam incident angles. This effect can be mini-
mized by modifying internal convolution grid and density
grid parameters for an individual case.
III.C. Measurement vs calculation in IMRT fields
Seven segmental IMRT fields were tested using XV film
on the flat phantom for normal and oblique incident angles.
Figure 8 shows the comparison of one example field field 1
mple fields at various depths for 0° incidence using  index 2%/2 mm and
s in agreement  , C1 for ROI10% of the maximum measured dose.
culations and measurements were acquired through averaging the doses for
average deviation in percentage was calculated from averaging the ratio of
e for all data points in ROI10% of the maximum measured dose.
dose Average deviation
%
 C
2%/2 mm
%
3%/3 mm
%
2%/1 mm
%
5%/1 mm
%
3.7 48 69 57 89
2.8 61 85 71 95
0.9 89 97 90 99
0.5 84 95 86 98
1.6 80 95 85 97
1.6 82 96 86 97
1.7 79 91 82 96
1.4 76 89 78 96
2.1 74 94 82 95
1.8 83 97 86 97
0.8 89 97 89 99
1.4 82 94 84 97
3.0 58 79 66 90
2.6 66 87 73 94
1.0 84 95 85 97
1.3 83 93 83 97
1.8 88 99 90 99
2.1 86 99 90 99
0.9 91 99 92 100
1.8 82 93 82 98
1.8 75 94 79 96
1.8 83 98 86 97
1.3 87 97 86 98
1.3 85 95 84 97
0.4 90 97 93 98
0.8 93 98 94 98
2.0 70 88 75 97
2.7 66 84 72 97exa
point
of cal
y. The
dos
eragefrom Table I for normal and oblique incidences for 2D dose
2051 Hsu et al.: Dose discrepancies in the buildup region 2051distributions. The displayed isodose lines are 20%, 50%, and
80% of maximum dose on the measured dose maps. Figure 9
shows an example of dose difference in cGy map at 2 mm
depth field 1. The dose difference is −2.6	3.4 cGy aver-
age and 1.
To quantify the range of disagreement, the C index was
used with criteria of 2%/l mm and 5%/l mm for the seven
IMRT fields. For comparison, the  index with criteria of
2%/2 mm and 3%/3 mm was also calculated. Table I shows
the comparison at 0° incidence. The C index with 2%/1 mm
tight criteria for IMRT fields ranged from 57% to 93% and
from 72% to 86% at 2 mm and 10 cm depths, respectively.
The C index with 5%/1 mm loose criteria for IMRT fields
ranged from 89% to 99% and from 96% to 98% at 2 mm and
10 cm depths, respectively. Both tight and loose criteria in
the C index show that the agreement in the buildup region is
comparable to that at 10 cm depth. The  index shows simi-
lar results. Table II shows the agreement in the buildup re-
gion for 45° incidence for selected fields. The agreement is
also comparable to that at 0° incidence and 10 cm depth.
Based on the results for 2D maps and the  and C indices,
the calculations agree well with the measurements in the
buildup region for IMRT fields. The deviations found in the
profiles for oblique incidences, i.e., disagreement near the
profile edge and ripple phenomenon Fig. 7, were partially
masked in IMRT comparisons by dose nonuniformity effects.
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FIG. 9. An example of dose difference between calculation and measure-
ment calculation minus measurement for IMRT field 1 at 2 mm depth and
0° incidence. The dose difference is −2.6	3.4 cGy in average and 1. The
maximum dose of the measurement is 69 cGy.
TABLE II. Comparison of film measurements and calculations for two IMRT
Field No.
Depth
cm Segments
Calculation average dose
cGy
Measurement av
cGy
1 0.3 183+101 37 38
1 0.6 183+101 45 46
1 1.4 183+101 50 50
3 0.3 127+149 22 23Medical Physics, Vol. 37, No. 5, May 2010Although the two indices show that the agreement is
good, the calculated dose was found lower at 2 and 5 mm
depths but higher at 1.5 cm and 10 cm depths Fig. 10. A
contributor to this systematic error could be measurement
error, e.g., applying the calibration curves of open fields to
IMRT fields. Errors in the calculation could also contribute
to this systematic error because the irradiation geometry is
not exactly represented by the calculation. The current EC
term in the calculation algorithm does not consider the com-
plexity of IMRT field delivery. Dogan et al.5 and Yokoyama
et al.49 have shown that the dose at near-surface depth is
lower for IMRT field delivery compared to open field deliv-
ery when the fluence pattern is the same. The reduction in
dose at 2 mm depth is 11% relative to dose at 10 cm
depth for ten static 110 cm2 strips compared to a
1010 cm2 open field.49 Irradiation conditions are different
between the fluence pattern used for the calculation and
IMRT delivery fields with varying MLC shape patterns cre-
ated during leaf sequencing. A small buildup dose discrep-
ancy caused by ignoring the MLC shape patterns in the cal-
culation was expected and may depend on IMRT pattern
complexity, but a dependence relationship could not be con-
cluded from the limited number of studied fields in this
work.
The parameters in the EC term could be fitted based on
either open or IMRT field geometries or a median solution,
depending on individual clinical concerns and TPS perfor-
mance. In this study, we fitted the parameters to open field
geometry at 0° incidence and evaluated the residual discrep-
mple fields at various depths for 45° incidence using  and C analyses.
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0.1 84 95 85 97
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FIG. 10. The average of deviations between calculations and measurements
for seven IMRT fields at various depths for 0° incidence average value and
1 shown.exa
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2052 Hsu et al.: Dose discrepancies in the buildup region 2052ancy for IMRT fields because near-surface dose is not only a
concern for IMRT treatments but also for conventional non-
IMRT treatments. Based on current results in studied irradia-
tion conditions, the calculation accuracy in the buildup re-
gion is within 4% for open and IMRT fields at normal and
oblique incidences. The added EC term in CVSP was deter-
mined to be adequate for both open and IMRT fields.
Further work on the verification of surface dose on a
curved surface e.g., cylindrical phantom with the full IMRT
plan could be done. The discrepancy between measurements
and calculations would be small for the multiple angles of
beam incidence relative to the phantom surface on the basis
of current results in the flat phantom geometry.
Many publications have reported accuracy for various
treatment planning algorithms.1–7 Dose disagreement at near-
surface depths has been found with a range of variation in
these studies. The calculation accuracy at near-surface depth
depends on institution TPS commissioning in the buildup
region e.g., accuracy of measurement and versatility of the
TPS algorithm, the complexity of treatment planning, and
the size of different types of grids. It is recommended that
users evaluate the buildup dose accuracy for their TPS using
clinically relevant treatment plans and grid sizes.
IV. CONCLUSIONS
The calculation accuracy in PDDs and profiles for open
fields has been improved by refitting parameters in the EC
term based on more accurate buildup dose measurements.
The main challenges in fitting profile measurements were the
disagreement near the profile penumbra and a ripple phe-
nomenon due to internal convolution grid effects for oblique
incidences. These challenges do not significantly affect rou-
tine IMRT dose calculations. The quality of agreement in the
buildup region for IMRT fields is comparable to the quality
of agreement in nonbuildup regions. The calculation accu-
racy in the buildup region is within 4% for open and IMRT
fields at normal and oblique incidences based on the results
in studied conditions. The added EC term serves the purpose
of supplementing the dose in the near-surface regions with
adequate accuracy. The accuracy of calculation in the
buildup region depends on methods used to parameterize the
calculation model for the TPS, the accuracy of the EC mod-
eling for various complexities of treatment plan, and the size
of different types of grids. It is recommended that users
evaluate the accuracy in the near-surface dose calculation for
individual TPS with treatment plans and grid sizes which are
typically used in clinic. Understanding the performance and
limitation for individual TPS in the buildup dose calculation
would provide helpful information when dose estimation at
near-surface depths is needed.
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